Acutaas Chemicals Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 10,00,453 shares,. Its Average Traded Price (ATP) is ₹3415.03, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 3 @ ₹3451.40.
Acutaas Chemicals has an upper circuit limit of ₹4141.60 and a lower circuit limit of ₹2761.20. The total value traded stands at ₹341.66 CR, and the delivery percentage for the day is 34.28%.
The stock is currently traded with a market lot size of 1. Acutaas Chemicals also offers a dividend yield of 0.08%.
Acutaas Chemicals Share Price Chart
Acutaas Chemicals Share Key Metrics
Volume
10.00 L
Market Cap
28257.00 CR
LTQ@LTP
3@3451.40
ATP
3415.03
Var Margin
100 %
Circuit Range
2761.2-4141.6
Delivery %
34.28 %
Value
341.66 CR
ASM/GSM
No
Market Lot
1
Acutaas Chemicals Resistance and Support
Pivot 3378.47
Resistance
First Resistance
3536.94
Second Resistance
3622.47
Third Resistance
3780.94
Support
First Support
3292.94
Second Support
3134.47
Third Support
3048.94
Acutaas Chemicals Shareholding Pattern
View More- 2018-19
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Acutaas Chemicals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-24 | Quarterly Results |
| 2026-04-30 | Audited Results & Final Dividend |
| 2026-01-28 | Quarterly Results |
| 2025-10-17 | Quarterly Results |
| 2025-07-30 | Quarterly Results |
| 2025-05-02 | Audited Results & Final Dividend |
| 2025-02-21 | Stock Split |
| 2025-01-28 | Quarterly Results |
| 2024-10-29 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2025-09-18 | 2025-09-18 | View More |
| Split Ratio | Split Date | |
|---|---|---|
| 2:1 | 2025-04-25 | View More |
Acutaas Chemicals News
Acutaas Chemicals Ltd - 543349 - Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 - Grant Of Patent
Acutaas Chemicals received a process patent for 2,4-DIMETHYLTHIOPHENOL, valid for 20 years from the filing date. This proprietary process, developed by the company's R&D Centre, increases its total patent portfolio to 11, indicating enhanced intellectual property.
Sep 10 2026 17:59:28
Acutaas Chemicals Ltd - 543349 - Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 - Inauguration Of New Pilot Plant
Ami Organics inaugurated a new state-of-the-art pilot plant at Unit 1 in Sachin, Surat. The plant will enhance R&D capabilities for new product trials and enable the scale-up of high-potency active pharmaceutical ingredients using OEB 4 containment.
Sep 04 2026 12:04:06
Acutaas Chemicals Ltd - 543349 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Acutaas Chemicals' step-down subsidiary, Indichem Inc., inaugurated a new semiconductor materials plant in Gongju, South Korea. This plant, completed in 11 months, is a joint venture focused on high-purity chemicals for semiconductor applications, with Acutaas's subsidiary investing KRW 30 billion (approx. Rs. 200 crore).
Aug 28 2026 08:51:25
Acutaas Chemicals Ltd - 543349 - Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
Ami Organics approved a capital expenditure of Rs. 212 crore for a new manufacturing plant in Gujarat. This investment aims to establish a greenfield or brownfield facility for producing new electronic grade chemicals, with completion by the end of FY2027-28.
Aug 22 2026 17:32:52
Acutaas Chemicals Ltd - 543349 - Intimation Under Regulation 30 Of SEBI LODR Regulations, 2015 - Approval Under ECMS Scheme
Acutaas Chemicals Limited has received approval for an incentive package under the Electronic Components Manufacturing Scheme (ECMS) for its Electrolyte Additives manufacturing business. The eligible investment for the scheme is Rs.119.12 crore, with expected benefits up to 25% by FY2030-31.
Aug 18 2026 10:49:17
Acutaas Chemicals Management
| Name | Position |
|---|---|
| Ekta K Srivastava | Company Secretary & Compliance Officer |
| Nareshkumar Patel | Chairman & Managing Director |
Acutaas Chemicals Similar Stocks
Dr. Lal Pathlabs Ltd.
1916.70
0.00 (0.00%)
Krishna Institute of Medical Sciences Ltd
772.80
0.00 (0.00%)
Rubicon Research Ltd.
1790.00
0.00 (0.00%)
Neuland Laboratories Ltd.
23800.00
0.00 (0.00%)
Piramal Pharma Ltd.
212.49
0.00 (0.00%)
Granules India Ltd.
899.25
0.00 (0.00%)
Caplin Point Laboratories Ltd.
2795.40
0.00 (0.00%)
Pfizer Ltd.
4095.40
0.00 (0.00%)
Astrazeneca Pharma India Ltd.
6860.50
0.00 (0.00%)
Acutaas Chemicals FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in ACUTAAS
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC